Jeffrey M. Saland, MD, MS (he/him/his)

Professor, Pediatric Nephrology and Hypertension
Icahn School of Medicine at Mount Sinai
New York, New York, United States

Presentation(s):

• Long-term Efficacy and Safety of Lumasiran in Patients with Primary Hyperoxaluria Type 1 in a Final Analysis of the ILLUMINATE-A Trial

  Friday, April 25, 2025
  4:15pm – 4:30pm HST

  Disclosure(s): Alnylam Pharmaceuticals (Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator, Speaker Honorarium including speakers bureau, symposia, and expert witness)